Table 1. Demographic and clinical characteristics.
FAK: focal adhesion kinase, IRS: immunoreactive score.
| n (%) | |
| Histologic type | |
| Clear cell | 58 (64.4) |
| Papillary | 15 (16.7) |
| Chromophobe | 11 (12.2) |
| Unclassified | 6 (6.37) |
| Grade | |
| Grade 1 | 9 (10) |
| Grade 2 | 45 (50) |
| Grade 3 | 30 (33.3) |
| Grade 4 | 6 (6.7) |
| Gender | |
| Male | 63 (70) |
| Female | 27 (30) |
| Stage Τ | |
| T1 | 63 (70) |
| T2 | 11 (12.2) |
| T3 | 16 (17.8) |
| Stage N | |
| N0 | 86 (95.6) |
| N1 | 2 (2.2) |
| N2 | 2 (2.2) |
| FAK negative | 40 (44.4) |
| Positive | 50 (55.6) |
| FAK intensity 1 | 44 (88) |
| 2 | 6 (12) |
| 3 | 0 (0) |
| Src negative | 61 (67.8) |
| Positive | 29 (32.2) |
| Src intensity 1 | 24 (82.8) |
| 2 | 5 (17.2) |
| 3 | 0 (0) |
| Paxillin negative | 73 (81.1) |
| Positive | 17 (18.9) |
| Paxillin intensity 1 | 10 (58.8) |
| 2 | 7 (41.2) |
| 3 | 0 (0) |
| Age mean ± SD (range) | 59.96 ± 12.96 (25-85) |
| FAK (%), mean ± SD (range) | 28.54 ± 18.01 (7-65) |
| Src (%), mean ± SD (range) | 23.45 ± 10.70 (10-50) |
| Paxillin (%), mean ± SD (range) | 25.88 ± 13.26 (10-60) |
| FAK IRS 0-1 | 51 (56.7) |
| 2-3 | 33 (36.7) |
| 4-8 | 6 (6.7) |
| Src IRS 0-1 | 65 (72.2) |
| 2-3 | 20 (22.2) |
| 4-8 | 5 (5.6) |
| Paxillin IRS 0-1 | 74 (82.2) |
| 2-3 | 9 (10.0) |
| 4-8 | 7 (7.8) |